Table 1 Baseline characteristics of patients stratified according to the sPD-L1 level.
Variable | sPD-L1 < 4.6 ng/mL (N = 52) | sPDL1 ≥ 4.6 ng/mL (N = 8) | P-value | |
|---|---|---|---|---|
Age, years | ≥60 | 23 (44.2) | 2 (25.0) | 0.449 |
<60 | 29 (55.8) | 6 (75.0) | ||
Sex | Male | 31 (59.6) | 2 (25.0) | 0.124 |
Female | 21 (40.4) | 6 (75.0) | ||
Disease extent | Locally advanced | 13 (25.0) | 1 (12.5) | 0.667 |
Metastatic | 39 (75.0) | 7 (87.5) | ||
CA19-9, U/mL | Elevated (≥37.0) | 39 (75.0) | 8 (100.0) | 0.182 |
Decreased (<37.0) | 13 (25.0) | 0 (0.0) | ||
Total bilirubin, mg/dL | Elevated (>1.2) | 12 (23.1) | 0 (0.0) | 0.338 |
Normal (≤1.2) | 40 (76.9) | 8 (100.0) | ||
Albumin, g/dL | Normal (≥3.3) | 49 (94.2) | 8 (100.0) | 1.000 |
Decreased (<3.3) | 3 (5.8) | 0 (0.0) | ||
NLR | Increased (≥1.83) | 41 (78.8) | 5 (62.5) | 0.374 |
Decreased (<1.83) | 11 (21.2) | 3 (37.5) | ||
NLR | Mean | 3.00 (±1.55) | 2.97 (±1.70) | 0.940 |
PLR | Increased (≥109.6) | 37 (71.2) | 6 (75.0) | 1.000 |
Decreased (<109.6) | 15 (28.8) | 2 (25.0) | ||
PLR | Mean | 156.6 (±60.01) | 171.8 (±72.55) | 0.388 |
